US 7989501
Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde
granted A61KA61K31/145A61K31/15
Quick answer
US patent 7989501 (Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/145, A61K31/15, A61K31/245, A61K31/277